Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,387 total articles
Vertiv (VRT) looks expensive on headline multiples, but its scale in power and cooling for AI data centers, a $2.3B free cash flow run-rate, and a $15B+ backlog make a disciplined long trade sensible. I outline a mid-term (45 trading days) swing plan with an entry at $318, stop at $290 and target at $380 — risk-weighted, catalyst-driven, and sized …
Ferrari pulled a headline move with its Luce EV reveal; social backlash and investor criticism knocked the stock lower, but fundamentals - scarce supply, industry-leading margins, strong pricing power and a $85.9B market cap - argue for buying dips. This trade lays out an actionable long-term entry with a tight stop and a clear target based on mean…
Taseko Mines (TGB) has moved from developer to producer as Florence Copper records its first cathode harvest and early ramp indicators. With a $2.64B market cap, stretched valuation metrics and a partially priced-in story, the stock offers a tradeable asymmetric opportunity while the market digests production proof. We recommend a tactical long for…
Nvidia (NVDA) remains the central beneficiary of surging AI infrastructure demand. Strong quarterly results, robust free cash flow, expanding addressable market via CPUs and ecosystem partnerships are generating durable pricing and volume tailwinds. Technicals show neutral momentum but volume and short interest dynamics leave room for a sustained m…
Antero Resources looks like a compelling long after recent weakness: solid balance sheet, sub-7x EV/EBITDA, and a path to much higher free cash flow in 2026 in a stronger gas price environment. Our projection models show the company capable of generating north of $1.7 billion in FCF in 2026 under conservative commodity and midstream assumptions. We…
F&G Annuities & Life is trading at single-digit multiples to book and depressed earnings expectations despite $73B AUM, steady sales and a consistent dividend. The market appears to be pricing in near-term execution risk; we see a mid-term swing opportunity with defined risk and >20% upside if fundamentals stabilize and insurers’ multiples re-rate.
Mastercard (MA) is a high-quality, cash-flowing payments network that benefits when consumers and businesses shift away from cash. With market cap near $436B, free cash flow of $17.8B, and an earnings multiple below many growth names, MA offers a trade to own a practical inflation and currency-debasement hedge. Enter around $494.00, target $560.00 …
Personalis is a small-cap cancer-testing specialist showing early signs of a commercial inflection: clinical test volumes for NeXT Personal rose 59% year-over-year even as revenue lagged. With a market cap near $1.15B, heavy institutional flows, and a stretched technical breakout, we initiate with a Buy, actionable entry, targets and stops tailored…
Ionis (IONS) sits on a constructive technical base and a heavy short-interest backdrop while the oligonucleotide/antisense sector is accelerating. With market cap at roughly $12.8B and clear trading support in the mid-$70s, we outline a swing trade to capture upside toward the 52-week high while limiting downside with a tight stop.
Procter & Gamble is a high-quality consumer staple with durable free cash flow, a long dividend streak and valuation that looks reasonable relative to cash generation. We view PG as a buy for patient, income-oriented investors but recommend a defined entry, stop and target to manage macro and execution risk.
Apogee Therapeutics is a clinical-stage biotech with a lead anti-IL-13 program, zumilokibart (APG777), that has shown strong durability in Phase 2 and a runway extended by recent equity raises. The shares pulled back into the low $70s and look like a tactical long for patient traders willing to ride clinical catalysts into late 2026. This trade ide…
The Western Union Company (WU) trades at roughly $8.10 and yields about 11.5% from an annualized dividend of $0.94. With a market cap near $2.53B, free cash flow of $377.7M and EV/EBITDA of 4.9x, WU looks cheap relative to its cash generation. This trade idea lays out an entry, stop and target with catalysts and clear risk controls for a long-term …
TG Therapeutics is a tactical buy after management signaled a stronger 2026 outlook tied to BRIUMVI expansion and continued commercial execution. The company now sports a roughly $6.0 billion market cap, improving revenue traction, and still-constructive valuation metrics versus growth prospects. This trade lays out entry, stop, and target levels a…
Nebius reported a 684% revenue surge that has captivated traders. That growth looks real on the top line, but a thin liquidity profile, likely one-time drivers and opaque cash flow dynamics create a measurable downside if earnings quality or cash visibility disappoint. This is a tactical short idea with clearly defined entry, stop and targets over …
MercadoLibre (MELI) is under pressure as management sacrifices margins to defend Latin American market share and scale fintech products. Current weakness creates a tradeable long opportunity: enter near $1690, stop at $1525, target $2400 over a long-term window (180 trading days). Expect volatility in the next 10-45 trading days as investments read…
Microsoft ($MSFT) trades well above its 50-day average and at a premium to the market, but fundamentals remain solid: $3.16T market cap, $72.9B free cash flow, 30% ROE, and low leverage. For traders willing to accept limited valuation risk, a controlled long with a $426 entry, $400 stop and $455 target over a mid-term (45 trading days) horizon bala…
Gentherm trades at an enterprise value below $1.11B with EV/Sales ~0.72 and free cash flow of $78.6M despite winning $620M in new automotive awards and expanding into home/office wellness. Technicals show strength but some overbought signals; a disciplined entry and stop give a favorable risk/reward for a mid-term trade.
Dave Inc. looks like a fintech that has graduated from early-stage promise to near-term commercial clarity. With 2025 revenue up roughly 60%, net income of $195.9M, strong free cash flow of $326.5M, and a market cap near $3.4B, Dave is delivering both growth and profitability. This trade plan targets $420 over a 180-trading-day window while protect…
Kohl's ($KSS) delivered an earnings beat while management signaled no new store closures and a focus on omnichannel execution. The stock has recovered from its spring lows and now trades on single-digit earnings multiples with a 3.9% yield and positive technical momentum. We upgrade to a tactical long for a mid-term swing (45 trading days) with a c…
Netflix is sitting above a clean technical and fundamental floor after a painful selloff. The business is cash-generative, has strong returns on capital, and recent one-time items that distorted reported EPS are fading. With a market cap near $361B, EV/EBITDA of 9.5 and free cash flow of roughly $11.9B, the risk-reward favors a tactical long: entry…
Applied Digital's latest 15-year, $7.5B lease for 300 MW at Polaris Forge 3 creates a measurable demand gap that has the market re-rating the stock. Bullish trade: enter $49.00, stop $44.00, primary target $62.00 and secondary target $75.00 over a mid-term (45 trading days) horizon. Valuation is rich, but contracted revenue and hyperscaler appetite…
AMD is positioned to capture meaningful AI-related revenue growth through EPYC CPUs, GPU accelerators and differentiated system-level wins. We upgrade AMD to a buy and present a concrete trade plan calibrated to a 180-trading-day horizon that assumes continued data-center demand and margin improvement without needing AMD to displace Nvidia outright…
Ulta Beauty has pulled back from its 52‑week highs and is trading at a mid‑teens P/E with robust free cash flow and almost no financial leverage. That combination, plus improving technicals and an earnings calendar, sets up a defined-risk swing trade heading into the next report.
Fabrinet (FN) provides precision optical packaging and manufacturing that sits beneath the headlines of AI chips and cloud racks. At a current price of $660.66, the company trades at a premium multiple but brings 17% ROE, $201.7M in free cash flow, a clean balance sheet and a string of record revenues. I’m bullish on a mid-term swing into the next …
Netflix is trading near $86 and sits below several short-term moving averages, which has traders calling it a bear market. I disagree. With roughly $12 billion in free cash flow, a market cap around $360 billion, and operating returns that remain industry-leading, Netflix can re-rate as ad monetization and live-sports initiatives scale. This articl…
